RSNA 2020 News

Bayer, Blackford team up on AI platform

By staff writers
December 1, 2020

Bayer has enlisted Blackford Analysis to develop a platform that will integrate artificial intelligence (AI) applications used in medical imaging.

Per a licensing and development deal, Blackford will develop the platform for Bayer, and Bayer will provide AI solutions of its own and from third parties. The companies announced the deal during the RSNA 2020 virtual conference being held this week.

The idea is to provide an integrated platform for AI applications that will work well within radiology department workflows and to connect imaging professionals to a virtual marketplace where they can access AI-related needs. An integrated platform will help radiologists meet the needs of an increasingly demanding work environment with better efficiency, according to the companies.

How good is the evidence supporting AI in radiology?
Just how good is the quality of scientific evidence supporting the use of artificial intelligence (AI) in radiology? The research study named the Scientific...
Bayer, Healthy Women launch breast density campaign
Bayer and HealthyWomen have launched the Understand Your Density campaign to increase women's awareness about their breast density and their needs for...
Bayer gets FDA nod for contrast with mammography
Contrast developer Bayer has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the use of its CT injectors for contrast-enhanced...
MaxQ AI's Accipio now on Blackford platform
Artificial intelligence (AI) software developer MaxQ AI announced that its Accipio intracranial hemorrhage software is now available on medical software...
RSNA's AI Showcase provides a deep experience
CHICAGO - Few technologies have shown growth as rapid as that of artificial intelligence (AI). Sadly, few have also shown such initially slow adoption...

Copyright © 2020

Last Updated mf 12/2/2020 9:25:00 AM